Are pretreatment inflammation-based prognostic scores useful in predicting the outcomes of patients with ALK-positive NSCLC?

Ölmez, O. F.Bilici, A.Gürsoy, P.Çubukcu, ErdemYıldız, O.Sakin, A.Korkmaz, T.Çil, I.Çakar, B.Menekşe, S.Demir, T.Açıkgöz, O.Hamdard, J.2024-11-192024-11-192019-10-011556-0864https://www.sciencedirect.com/science/article/pii/S1556086419318350https://hdl.handle.net/11452/48093eninfo:eu-repo/semantics/openAccessInflammation-based prognostic scoresNon small cell lung cancerAnaplastic lymphoma kinaseScience & technologyLife sciences & biomedicineOncologyRespiratory systemAre pretreatment inflammation-based prognostic scores useful in predicting the outcomes of patients with ALK-positive NSCLC?Meeting Abstract000492162203068S551S55214101556-1380